Back
BioCardia 10K Form
Sell
31
BCDA
BioCardia
Last Price:
2.40
Seasonality Move:
6.94%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BCDA News And Ratings
See the #1 stock for the next 7 days that we like better than BCDA
BCDA Financial Statistics
Sales & Book Value
| Annual Sales: | $477K |
|---|---|
| Cash Flow: | $-1.32M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.92 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -5.38000 |
|---|---|
| Net Income (TTM): | $-8.56M |
| Gross Margin: | $1.02M |
| Return on Equity: | 0% |
| Return on Assets: | -228.95% |
BioCardia Earnings Forecast
Key BioCardia Financial Ratios
- The Gross Profit Margin over the past 26 years for BCDA is 100.49%.
- The Selling, General & Administrative Expenses for BCDA have been equal to 921.38% of Gross Profit Margin.
- The Research & Development expenses have been 1,619.71% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of BCDA is -2,425.79% of Total Revenues.
- Per Share Earnings over the last 28 years have been positive in 17 years.
BioCardia Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BCDA |
| Website: | biocardia.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0.39 |
| Quick Ratio: | 0.35 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |